NASDAQ : IVVD
Invivyd, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 0.5817 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 171.46M |
| Enterprise Value | 19.77M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 294.76M |
| Shares Outstanding | 294.76M |
| Shares Change (YoY) | +125.22% |
| Shares Change (QoQ) | +3.48% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 63.99% |
| Float | 207.83M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.94 |
| Forward PS | 2.58 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.87 |
| Quick Ratio | 5.54 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -95.89% |
| Return on Assets (ROA) | -45.67% |
| Return on Invested Capital (ROIC) | -59.80% |
| Return on Capital Employed (ROCE) | -59.90% |
| Weighted Average Cost of Capital (WACC) | 9.02% |
| Revenue Per Employee | $478,402 |
| Profits Per Employee | -$879,779 |
| Employee Count | 122 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 12.19 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -69.70% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 36.54 |
| Average Volume (20 Days) | 4,436,658 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 37.05M |
| Short Previous Month | 33.86M |
| Short % of Shares Out | 12.57% |
| Short % of Float | 17.83% |
| Short Ratio (days to cover) | 5.01 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 58.37M |
| Gross Profit | 53.83M |
| Operating Income | -112.53M |
| Pretax Income | -107.33M |
| Net Income | -107.33M |
| EBITDA | -111.89M |
| EBIT | -112.53M |
| Loss Per Share | -$0.40 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 160.08M |
| Total Debt | 8.39M |
| Net Cash | 151.69M |
| Net Cash Per Share | $0.51 |
| Equity (Book Value) | 181.08M |
| Book Value Per Share | 0.61 |
| Working Capital | 151.08M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -108.42M |
| Capital Expenditures | -1.24M |
| Depreciation & Amortization | 646,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -109.66M |
| FCF Per Share | -$0.37 |
Margins
| Measure | Value |
|---|
| Gross Margin | 92.23% |
| Operating Margin | -192.81% |
| Pretax Margin | -183.90% |
| Profit Margin | -183.90% |
| EBITDA Margin | -191.70% |
| EBIT Margin | -192.81% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -125.22% |
| Shareholder Yield | -125.22% |
| Earnings Yield | -68.40% |
| FCF Yield | -63.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $10.00 |
| Price Target Difference | 1,619.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 62.69% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.17 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |